Snx2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
[^2]
[^3]
[^4]
[^5]
[^6]
[^7]
| SNX2 Protein |
|---|
| Protein Name | Sorting Nexin 2 |
| Alternative Names | SNX2 |
| UniProt ID | [O60613](https://www.uniprot.org/uniprot/O60613) |
| Gene Symbol | SNX2 |
| Protein Type | Sorting nexin, membrane trafficking protein |
| Molecular Weight | ~47 kDa (472 aa) |
| Cellular Location | Cytoplasm, Endosomal membranes |
This page provides comprehensive information about the subject's role in neurodegenerative diseases. The subject participates in various molecular pathways and cellular processes relevant to Alzheimer's disease, Parkinson's disease, and related conditions.
SNX2 shares structural features with SNX1:
- PX Domain: Phosphoinositide-binding module
- Bar Domain: Membrane deformation capability
- Coiled-coil regions: Protein interactions
SNX2 operates in:
- Heterodimer Formation: Pairs with SNX1 for cargo recognition
- Retromer Recruitment: Part of the sorting nexin family that comprises the retromer
- Endosomal Sorting: Directs proteins to lysosomal degradation
- Autophagy: Participates in selective autophagy pathways
| Partner |
Interaction Type |
Functional Significance |
| SNX1 |
Heterodimer |
Cargo sorting |
| SNX5/SNX6 |
Complex |
Retromer function |
| VPS26 |
Complex |
Retromer recruitment |
SNX2 plays a significant role in Alzheimer's disease pathogenesis through its involvement in APP trafficking and processing:
- Amyloid Precursor Protein (APP) Trafficking: SNX2, as part of the retromer complex, directs APP from the Golgi to the endosomal pathway. Dysregulation leads to increased amyloid-beta production
- Endosomal Trafficking Dysfunction: Early AD pathology shows enlarged endosomes; SNX2 knockdown in neuronal cultures increases amyloid-beta secretion
- Retromer-Mediated Recycling: The SNX2-SNX5-SNX6 heterotrimer recycles APP away from the amyloidogenic pathway
In PD, SNX2 intersects with several key pathogenic pathways:
- LRRK2 Pathogenesis: LRRK2 G2019S mutation causes increased SNX2 phosphorylation, affecting retromer function
- alpha-Suclein Trafficking: SNX2 regulates trafficking of alpha-synuclein and its interaction with synaptic vesicles
- GBA-Associated PD: GBA mutations reduce glucocerebrosidase activity, leading to SNX2-dependent lysosomal trafficking defects
- LRRK2 Pathway: LRRK2 kinase activity phosphorylates SNX2, disrupting retromer cargo sorting
- Retromer Stabilizers: Small molecules that enhance SNX2-retromer binding show promise in preclinical models
- Gene Therapy: SNX2 overexpression restores retromer function in cellular models of AD and PD
- LRRK2 Inhibitors: Combined approach with SNX2 modulation may provide synergistic benefits
flowchart TD
A["SNX2"] --> B["Retromer Complex"]
B --> C["VPS26"]
B --> D["VPS29"]
B --> E["VPS35"]
C --> F["Cargo Recognition"]
D --> G["SNX2/SNX5/SNX6"]
E --> H["Membrane Association"]
F --> I["APP Trafficking"]
G --> J["LRRK2 Interaction"]
I --> K["Amyloid Processing"]
J --> L["alpha-Synuclein Trafficking"]
K --> M["Alzheimer's Disease"]
L --> N["Parkinson's Disease"]